[Abrogation of leukocyte-inhibiting-factor endotoxin production (LIF endotoxin) by tilorone-stimulated human lymphocytes. Preliminary approach]. 1977

E Jirille, and D Fumarola, and R Monne, and I Munne

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007158 Immunologic Techniques Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies. Antibody Dissociation,Immunologic Technic,Immunologic Technics,Immunologic Technique,Immunological Technics,Immunological Techniques,Technic, Immunologic,Technics, Immunologic,Technique, Immunologic,Techniques, Immunologic,Antibody Dissociations,Dissociation, Antibody,Dissociations, Antibody,Immunological Technic,Immunological Technique,Technic, Immunological,Technics, Immunological,Technique, Immunological,Techniques, Immunological
D007957 Leukocyte Adherence Inhibition Test Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor. LAI Test,LAI Tests,Test, LAI,Tests, LAI
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D005449 Fluorenes A family of diphenylenemethane derivatives.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013994 Tilorone An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions. Amyxin,Bis-DEAE-Fluorenone,Amiksin,Amixin,Tilorone Hydrochloride,Bis DEAE Fluorenone,Hydrochloride, Tilorone

Related Publications

E Jirille, and D Fumarola, and R Monne, and I Munne
August 1976, Bollettino della Societa italiana di biologia sperimentale,
E Jirille, and D Fumarola, and R Monne, and I Munne
January 1976, Bollettino dell'Istituto sieroterapico milanese,
E Jirille, and D Fumarola, and R Monne, and I Munne
January 1978, Annali Sclavo; rivista di microbiologia e di immunologia,
E Jirille, and D Fumarola, and R Monne, and I Munne
March 1977, Bollettino dell'Istituto sieroterapico milanese,
E Jirille, and D Fumarola, and R Monne, and I Munne
September 1977, Bollettino dell'Istituto sieroterapico milanese,
E Jirille, and D Fumarola, and R Monne, and I Munne
July 1975, Journal of immunology (Baltimore, Md. : 1950),
E Jirille, and D Fumarola, and R Monne, and I Munne
February 1981, Clinical immunology and immunopathology,
E Jirille, and D Fumarola, and R Monne, and I Munne
February 1981, Clinical immunology and immunopathology,
E Jirille, and D Fumarola, and R Monne, and I Munne
April 1975, Journal of immunology (Baltimore, Md. : 1950),
E Jirille, and D Fumarola, and R Monne, and I Munne
December 1975, Clinical and experimental immunology,
Copied contents to your clipboard!